OM
Opaleye Management’s Sangamo Therapeutics SGMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,055,000
| Closed | -$692K | – | 47 |
|
2025
Q1 | $692K | Buy |
+1,055,000
| New | +$692K | 0.15% | 41 |
|
2019
Q1 | – | Sell |
-500,000
| Closed | -$5.74M | – | 59 |
|
2018
Q4 | $5.74M | Buy |
500,000
+10,000
| +2% | +$115K | 2.14% | 16 |
|
2018
Q3 | $8.31M | Sell |
490,000
-15,000
| -3% | -$254K | 2.11% | 16 |
|
2018
Q2 | $7.17M | Sell |
505,000
-30,000
| -6% | -$426K | 1.86% | 19 |
|
2018
Q1 | $10.2M | Sell |
535,000
-45,000
| -8% | -$855K | 2.91% | 10 |
|
2017
Q4 | $9.51M | Hold |
580,000
| – | – | 3.05% | 10 |
|
2017
Q3 | $8.7M | Hold |
580,000
| – | – | 3.08% | 9 |
|
2017
Q2 | $5.1M | Sell |
580,000
-1,000
| -0.2% | -$8.8K | 2.13% | 16 |
|
2017
Q1 | $3.02M | Buy |
581,000
+181,000
| +45% | +$941K | 1.5% | 23 |
|
2016
Q4 | $1.22M | Buy |
+400,000
| New | +$1.22M | 0.72% | 34 |
|
2016
Q1 | – | Sell |
-60,000
| Closed | -$548K | – | 58 |
|
2015
Q4 | $548K | Buy |
+60,000
| New | +$548K | 0.23% | 51 |
|